Clinical trial NCT04155320: Impart: Provider-Assisted HIV Partner Notification
Official title: Provider-Assisted HIV Partner Notification & Testing With Prisoners in Indonesia: A Randomized Controlled Trial
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: HIV Infections
Partner Communication
Keywords: contact tracing
HIV prevention
partner notification
Lead sponsor: University of Illinois at Chicago
Sponsor class: OTHER
Collaborators: name: Indonesia University
name: National Institute of Mental Health (NIMH)
First posted: 2019-11-07
Enrollment: 55
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: DIAGNOSTIC

Brief summary: Researchers will conduct a 2-arm pilot randomized controlled trial with HIV-infected index patients recruited from two all-male prisons in Indonesia to assess the acceptability and feasibility of provider-assisted HIV partner notification (provider referral) and examine its potential to increase the number of partners who are tested for HIV and subsequently linked to prevention and treatment services.

Detailed description: This study compares three options for partner notification:

* Option 1 (Self-tell): Participant is encouraged to disclose his HIV+ status to his partner(s) and given information about sites where his partner(s) can receive free HIV testing.
* Option 2 (Tell together): Participant discloses his HIV+ status to his partners with a counselor (project staff) present. Counselor refers the partner to HIV testing, including a study-affiliated HIV testing site.
* Option 3 (Provider referral): Project staff (nurse or peer educator) will notify the partner anonymously - without identifying the participant (index patient). Partners are offered immediate HIV testing in their home or at a study-affiliated HIV testing site.

Eligibility criteria: Inclusion Criteria for HIV-positive Prisoners (N=65): Index patients must beat least 18 years of age, HIV-seropositive and aware of their HIV+ status; (HIV-infection documented by a rapid HIV test); sexually active and/or sharing needles in the 12 months before incarceration; incarcerated within the past 3 years and ≥6 months of their prison sentence remaining. We will limit enrollment to index patients who are willing to notify partners and have 1 or more partner(s) who have not yet been notified.

Inclusion Criteria for Partners: Eligible partners will be persons who participants (index patients) are able to identify by first and/or last name, residential address and/or mobile phone number, and physical descriptors (e.g., approximate height) and have given nurses permission to contact. No named partner will be excluded on the basis of religion, ethnicity, age, sex, or gender identity.

Primary outcomes:
measure: Notified
timeFrame: 6 weeks from index patient enrollment
measure: Tested
timeFrame: 6 weeks from index patient enrollment
measure: Diagnosed
timeFrame: 6 weeks from index patient enrollment
Secondary outcomes:
measure: Linked to Care
timeFrame: 6 weeks from index patient enrollment
measure: Initiated ART
timeFrame: 6 weeks from index patient enrollment
Other outcomes:
Locations:
city: Jakarta Pusat
country: Indonesia
facility: Rutan Cipinang
state: Jawa Barat
Study officials:
References: